IP Library Granted Patent US 9,238,801
Granted Patent B2
US 9,238,801 · App. 13/838,869 · Granted Jan 19, 2016

Ketol-acid reductoisomerase using NADH

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,238,801
App. No.
13/838,869
Granted
Jan 19, 2016
Kind
B2
Abstract

Methods for the evolution of NADPH specific ketol-acid reductoisomerase enzymes to acquire NADH specificity are provided. Specific mutant ketol-acid reductoisomerase enzymes isolated from Pseudomonas that have undergone co-factor switching to utilize NADH are described.

Claims (11)

1. A recombinant mutant ketol-acid reductoisomerase enzyme having the amino acid sequence of SEQ ID NO: 29.

2. The recombinant mutant ketol-acid reductoisomerase enzyme of claim 1 , wherein the enzyme comprises a substitution at position 24 wherein the substitution is an amino acid substitution of phenylalanine.

3. The recombinant mutant ketol-acid reductoisomerase enzyme of claim 1 , wherein the enzyme comprises a substitution at position 50 wherein the substitution is an amino acid substitution of alanine.

4. The recombinant mutant ketol-acid reductoisomerase enzyme of claim 1 , wherein the enzyme comprises a substitution at position 52 wherein the substitution is an amino acid substitution of aspartic acid.

5. The recombinant mutant ketol-acid reductoisomerase enzyme of claim 1 , wherein the enzyme comprises a substitution at position 53 wherein the substitution is an amino acid substitution of alanine.

6. The recombinant mutant ketol-acid reductoisomerase enzyme of claim 1 , wherein the enzyme comprises a substitution at position 61 wherein the substitution is an amino acid substitution of phenylalanine.

7. The recombinant mutant ketol-acid reductoisomerase enzyme of claim 1 , wherein the enzyme further comprises a substitution at position 115 wherein the substitution is an amino acid substitution of leucine.

8. The recombinant mutant ketol-acid reductoisomerase enzyme of claim 1 , wherein the enzyme further comprises a substitution at position 165 wherein the substitution is an amino acid substitution of methionine.

9. The recombinant mutant ketol-acid reductoisomerase enzyme of claim 1 , wherein the enzyme comprises a substitution at position 33 wherein the substitution is an amino acid substitution of leucine.

10. The recombinant mutant ketol-acid reductoisomerase enzyme of claim 1 , wherein the enzyme comprises a substitution at position 80 wherein the substitution is an amino acid substitution of isoleucine.

11. The recombinant mutant ketol-acid reductoisomerase enzyme of claim 1 , wherein the enzyme comprises a substitution at position 156 wherein the substitution is an amino acid substitution of valine.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2023
From: LI, YOUGEN; LIAO, DER-ING; NELSON, MARK J.; OKEEFE, DANIEL P.
To: E. I. DU PONT DE NEMOURS AND COMPANY
Reel/Frame 062400/0751 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2021
From: BUTAMAX ADVANCED BIOFUELS LLC
To: GEVO, INC.
Reel/Frame 057677/0477 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2021
From: TOMB, JEAN-FRANCOIS
To: BUTAMAX(TM) ADVANCED BIOFUELS LLC
Reel/Frame 057305/0763 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2021
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: BUTAMAX ADVANCED BIOFUELS LLC
Reel/Frame 057299/0663 →